SCHEMBL6979011

SCHEMBL6979011

CC(C)c1nc(-c2cnccc2C(F)(F)F)no1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.46
HTT P42858 1/20 0.42
S1PR3 Q99500 2/20 0.42
PLAT P00750 1/20 0.42
DPP4 P27487 1/20 0.42
DPP7 Q9UHL4 1/20 0.42
CNR2 P34972 2/20 0.40
ALDH1A1 P00352 5/20 0.40
HDAC1 Q13547 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC4 P56524 2/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979805 0.82 DPP4 (0.57) S1PR1HTTDPP4DPP7ALDH1A1
SCHEMBL6986703 0.82 S1PR1 (0.51) S1PR1S1PR3PLATALDH1A1KDM4E
SCHEMBL6781723 0.76 S1PR1 (0.43) S1PR1S1PR3PLATCNR2ALDH1A1
SCHEMBL23082900 0.76 DPP4 (0.42) S1PR1HTTS1PR3DPP4DPP7
SCHEMBL6785923 0.76 S1PR1 (0.61) S1PR1S1PR3ALDH1A1KDM4EMAPT
SCHEMBL6782004 0.75 S1PR1 (0.56) S1PR1HTTS1PR3PLATALDH1A1
SCHEMBL6779997 0.74 NPC1 (0.60) S1PR1HTTS1PR3PLATALDH1A1
SCHEMBL6780809 0.74 S1PR1 (0.67) S1PR1S1PR3PLATHPGDRAB9A
SCHEMBL6780851 0.74 S1PR1 (0.55) S1PR1S1PR3PLATALDH1A1KDM4E
SCHEMBL6778666 0.73 S1PR1 (0.57) S1PR1HTTS1PR3PLATRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183276-B2 Therapeutic agents MERCK SHARP & DOHME CORP. 2012-05-22 US disclosed
US-20100324029-A1 THERAPEUTIC AGENTS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324029-A1 THERAPEUTIC AGENTS PSEN2, PSEN1, BACE2 S1PR1 2711/4885HTT 9/4885S1PR3 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.